Martin Gertsch

Président chez Artidis AG

Profil

Martin Gertsch is currently the Chairman at Artidis AG, Director at the University of Basel, and Director at Centro Universitário da FEI.
He previously held the position of Vice Chairman at Santhera Pharmaceuticals Holding AG from 2017 to 2021.
He also served as Director at Symetis SA, Evolva Holding SA, Acino International AG, Synthes, Inc., and Acino Pharma AG.
Mr. Gertsch was the Chief Financial Officer at Acino International AG from 2013 to 2014 and at Cell Medica Switzerland AG from 2009 to 2010.
He was also the Head-Finance EMEA Region at Synthes, Inc. and the Vice President & Head-EMEA Finance at DePuy Synthes, Inc. Prior to that, he worked as the Chief Financial Officer at Straumann Holding AG from 2002 to 2006 and as the Chief Financial Officer at ESBATech AG from 2007 to 2009.
Mr. Gertsch started his career as an Audit Engagement Manager at PricewaterhouseCoopers, Inc. from 1986 to 1997.

Postes actifs de Martin Gertsch

Sociétés	Poste	Début
Centro Universitário da FEI	Directeur/Membre du Conseil	-
University of Basel	Directeur/Membre du Conseil	-
Artidis AG	Président	-

Anciens postes connus de Martin Gertsch

Sociétés	Poste	Fin
SANTHERA PHARMACEUTICALS HOLDING AG	Président	04/04/2017
ACINO HOLDING AG	Directeur Financier/CFO	14/01/2014
Acino Pharma AG	Directeur Financier/CFO	01/01/2014
Cell Medica Switzerland AG	Directeur Financier/CFO	01/01/2010
ESBATech, a Novartis Co. GmbH	Directeur Financier/CFO	01/09/2009